WS Data Solutions
Discounted Cash Flow Rating
Buy
Return on Equity Rating
Strong Sell
Debt to Equity Rating
Sell
Price to Earnings Rating
Buy
Analyst Rating
Neutral
Wall Street Data Solutions Rating
Neutral
B
Cybin Inc. (CYBN)
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds and protocols as potential treatments for various psychiatric and neurological conditions.
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
11/10/2020
Market Cap
190,150,908
Shares Outstanding
405,910,000
Weighted SO
406,441,253
Total Employees
N/A
Upcoming Earnings
N/A
Beta
0.9370
Last Div
0.0000
Range
0.24-0.738
Chg
-0.0143
Avg Vol
4692354
Mkt Cap
190150908
Exch
AMEX
Country
CA
Phone
908 764 8385
DCF Diff
0.0520
DCF
0.2000
Div Yield
0.0000
P/S
0.0000
EV Multiple
-0.8454
P/FV
0.9115
Div Yield %
0.0000
P/E
-3.2538
PEG
-0.0597
Payout
0.0000
Current Ratio
41.6966
Quick Ratio
41.6966
Cash Ratio
38.0633
DSO
0.0000
DIO
0.0000
Op Cycle
0.0000
DPO
3407.9006
CCC
0.0000
Gross Margin
0.0000
Op Margin
0.0000
Pretax Margin
0.0000
Net Margin
0.0000
Eff Tax Rate
0.0726
ROA
-0.2754
ROE
-0.4230
ROCE
-0.3285
NI/EBT
1.0000
EBT/EBIT
0.8528
EBIT/Rev
0.0000
Debt Ratio
0.0007
D/E
0.0008
LT Debt/Cap
0.0000
Total Debt/Cap
0.0008
Int Coverage
0.0000
CF/Debt
-402.9481
Equity Multi
1.0172
Rec Turnover
0.0000
Pay Turnover
0.1071
Inv Turnover
0.0000
FA Turnover
0.0000
Asset Turnover
0.0000
OCF/Share
-0.1148
FCF/Share
-0.1160
Cash/Share
0.2463
OCF/Sales
0.0000
FCF/OCF
1.0103
CF Coverage
-402.9481
ST Coverage
-402.9481
CapEx Coverage
-96.8537
Div&CapEx Cov
-96.8537
P/BV
0.9115
P/B
0.9115
P/S
0.0000
P/E
-3.2538
P/FCF
-3.0166
P/OCF
-2.9858
P/CF
-2.9858
PEG
-0.0597
P/S
0.0000
EV Multiple
-0.8454
P/FV
0.9115
DPS
0.0000